Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Aeglea BioTherapeutics, Inc. (AGLE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/30/2023 |
3
| Fairmount Funds Management LLC (10% Owner) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 06/30/2023 |
3
| Turtle Cameron (Chief Operating Officer) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 06/30/2023 |
3
| HENDERSON MICHAEL THOMAS (Director) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 01/27/2023 |
3
| Neuman Linda L (Chief Medical Officer) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 12/01/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/25/2022 |
3
| Kastenmayer James Paul (Interim CEO & General Counsel) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 11/16/2021 |
3
| Smith Hunter C (Director) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 07/08/2021 |
3
| Alspaugh Jonathan (CFO) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 06/22/2021 |
3
| Souza Marcio (Director) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 02/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/08/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/17/2020 |
3
| Lawton Alison Frances (Director) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 11/04/2019 |
3
| Rao Madduri Ravin (Chief Medical Officer) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 10/23/2019 |
3
| Hanley Jr. Michael Conick (Chief Commercial Officer) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 03/08/2019 |
3
| Sloan Leslie (COO) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 07/17/2018 |
3
| LAWLIS V BRYAN (Director) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 03/26/2018 |
3
| Magovcevic Ivana (Director) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 07/10/2017 |
3
| Wooldridge James (Chief Medical Officer) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 06/14/2017 |
3
| Schuchart Aaron (Chief Business Officer) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 02/16/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 05/19/2016 |
3
| Rojas-Caro Sandra (Chief Medical Officer) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 04/19/2016 |
3
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 04/06/2016 |
3
| Novartis Bioventures Ltd (10% Owner) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 04/06/2016 |
3
| Rowlinson Scott W (VP, Research) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 04/06/2016 |
3
| Mahatme Sandesh (Director) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 04/06/2016 |
3
| Cox Russell J. (Director) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 04/06/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 04/06/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 04/06/2016 |
3
| Hebel Henry (VP, Product Development) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 04/06/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 04/06/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 04/06/2016 |
3
| York Charles N II (CFO and VP) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 04/06/2016 |
3
| Shanafelt Armen (10% Owner) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
|
|